DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) announced a quarterly dividend on Wednesday, May 24th, Zacks reports. Stockholders of record on Friday, June 30th will be given a dividend of 0.14 per share by the medical instruments supplier on Friday, July 14th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date is Thursday, June 29th. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.13.
DENTSPLY SIRONA has increased its dividend by an average of 10.1% per year over the last three years and has raised its dividend every year for the last 12 years. DENTSPLY SIRONA has a dividend payout ratio of 24.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect DENTSPLY SIRONA to earn $2.26 per share next year, which means the company should continue to be able to cover its $0.56 annual dividend with an expected future payout ratio of 24.8%.
DENTSPLY SIRONA Stock Down 0.6 %
XRAY opened at $36.91 on Friday. DENTSPLY SIRONA has a fifty-two week low of $26.48 and a fifty-two week high of $43.24. The business has a 50-day moving average of $39.78 and a 200-day moving average of $36.03. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.93. The company has a market capitalization of $7.84 billion, a PE ratio of 13.91, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91.
Insider Transactions at DENTSPLY SIRONA
In other news, Director Eric Brandt sold 6,200 shares of the business’s stock in a transaction on Tuesday, May 2nd. The stock was sold at an average price of $42.17, for a total transaction of $261,454.00. Following the completion of the sale, the director now owns 44,902 shares in the company, valued at $1,893,517.34. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, SVP Cord Friedrich Staehler sold 4,000 shares of the business’s stock in a transaction on Tuesday, March 7th. The stock was sold at an average price of $39.33, for a total transaction of $157,320.00. Following the completion of the sale, the senior vice president now owns 97,693 shares in the company, valued at $3,842,265.69. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Eric Brandt sold 6,200 shares of the company’s stock in a transaction dated Tuesday, May 2nd. The shares were sold at an average price of $42.17, for a total value of $261,454.00. Following the completion of the sale, the director now owns 44,902 shares of the company’s stock, valued at approximately $1,893,517.34. The disclosure for this sale can be found here. 0.74% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On DENTSPLY SIRONA
A number of institutional investors and hedge funds have recently added to or reduced their stakes in XRAY. Parkside Financial Bank & Trust increased its holdings in DENTSPLY SIRONA by 163.7% in the first quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock valued at $46,000 after purchasing an additional 568 shares during the last quarter. Bessemer Group Inc. increased its holdings in DENTSPLY SIRONA by 47.0% in the fourth quarter. Bessemer Group Inc. now owns 1,846 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 590 shares during the last quarter. Covestor Ltd increased its holdings in DENTSPLY SIRONA by 97.8% in the first quarter. Covestor Ltd now owns 3,198 shares of the medical instruments supplier’s stock valued at $157,000 after purchasing an additional 1,581 shares during the last quarter. Veritable L.P. bought a new stake in DENTSPLY SIRONA in the first quarter valued at about $202,000. Finally, Advisor Partners II LLC bought a new stake in DENTSPLY SIRONA in the first quarter valued at about $203,000. Institutional investors own 98.52% of the company’s stock.
Analysts Set New Price Targets
Several analysts recently commented on the company. Morgan Stanley boosted their price target on DENTSPLY SIRONA from $39.00 to $45.00 and gave the company an “overweight” rating in a research note on Wednesday, April 19th. Robert W. Baird boosted their price target on DENTSPLY SIRONA from $36.00 to $46.00 in a research note on Thursday, May 4th. The Goldman Sachs Group lifted their price objective on DENTSPLY SIRONA from $34.00 to $39.00 and gave the company a “neutral” rating in a research report on Wednesday, March 1st. TheStreet upgraded DENTSPLY SIRONA from a “d+” rating to a “c” rating in a research report on Tuesday, February 28th. Finally, Piper Sandler lifted their price objective on DENTSPLY SIRONA from $29.00 to $35.00 and gave the company a “neutral” rating in a research report on Monday, February 6th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $42.13.
DENTSPLY SIRONA Company Profile
Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.
- Get a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)
- 3 Electrical Gear Makers: Hidden Gems Amid Growing Digitization
- Can ULTA’s Defensive Product Line Stand Against This Down Cycle
- A Reversal Is Brewing For Medtronic: Buying The Dip
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.